A 52-year-old man from Delhi presents with a 6-month history of progressive dyspnea, dry cough, and chest tightness. High-resolution CT chest shows bilateral upper lobe predominant reticulonodular opacities with hilar lymphadenopathy. Serum ACE level is elevated at 68 U/L (normal <40). Chest X-ray shows Scadding stage II changes. What is the most appropriate next step in management?

Explanation

## Clinical Context: Suspected Sarcoidosis — Need for Tissue Diagnosis The patient presents with features highly suggestive of pulmonary sarcoidosis: - Bilateral upper lobe reticulonodular opacities with hilar lymphadenopathy - Elevated serum ACE (68 U/L; normal <40) - Scadding stage II (bilateral hilar lymphadenopathy + parenchymal infiltrates) ## Why EBUS-TBNA is the Most Appropriate Next Step? **Key Point:** Sarcoidosis is a **diagnosis of exclusion** requiring histopathological confirmation of non-caseating granulomas before any treatment is initiated. Clinical features and elevated ACE are supportive but NOT diagnostic — tuberculosis, lymphoma, fungal infections, and other granulomatous diseases can mimic this presentation exactly. **High-Yield (Harrison's Principles of Internal Medicine, 21st ed.):** The diagnostic workup of suspected sarcoidosis mandates tissue biopsy to demonstrate non-caseating granulomas and exclude other causes. EBUS-TBNA has a diagnostic yield of **>80%** for mediastinal/hilar lymphadenopathy in sarcoidosis and is the preferred minimally invasive approach per ATS/ERS/WASOG guidelines. **Clinical Pearl:** In a patient from Delhi (high TB-endemic region), initiating corticosteroids without histological confirmation risks catastrophic dissemination of undiagnosed tuberculosis. Tissue diagnosis is therefore non-negotiable before treatment. ## Why Other Options Are Incorrect? | Option | Reasoning | |---|---| | **A) Serum/urinary calcium** | Important safety screening, but comes AFTER diagnosis is confirmed — not the immediate next step before tissue biopsy | | **B) Immediate corticosteroids** | Contraindicated without tissue diagnosis, especially in a TB-endemic region | | **D) PFT and 6MWT** | Useful for baseline functional assessment but secondary to establishing the diagnosis | ## Management Algorithm for Suspected Sarcoidosis ``` Suspected Sarcoidosis ↓ Tissue biopsy (EBUS-TBNA) → Non-caseating granulomas confirmed ↓ Metabolic screening (serum Ca²⁺, 24-h urinary Ca²⁺, renal function) ↓ Organ involvement assessment (PFT, DLCO, ECG, ophthalmology) ↓ Treatment decision (corticosteroids if symptomatic/progressive) ``` **Key Point:** The correct sequence is: **(1) Confirm diagnosis histologically → (2) Screen for metabolic complications → (3) Assess organ involvement → (4) Initiate therapy.** EBUS-TBNA is the most appropriate immediate next step. ## Additional Investigations After Diagnosis | Investigation | Purpose | Timing | |---|---|---| | EBUS-TBNA | Histological confirmation | **Immediate (next step)** | | Serum calcium, 24-h urine calcium | Hypercalcemia/hypercalciuria screening | After diagnosis confirmed | | PFT with DLCO | Assess pulmonary function | After diagnosis confirmed | | Ophthalmology referral | Uveitis screening | Before steroids | | Cardiac imaging (ECG, echo) | Exclude cardiac sarcoidosis | If symptoms warrant |